Glioma
2 competing products in clinical development for Glioma.
Pipeline by Phase
Phase 12
All Products (2)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| LY2157299 + Lomustine | Eli Lilly | Phase 1 | Completed | 33 |
| Temozolomide | Novocure | Phase 1 | Terminated | 28 |
2 competing products in clinical development for Glioma.
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| LY2157299 + Lomustine | Eli Lilly | Phase 1 | Completed | 33 |
| Temozolomide | Novocure | Phase 1 | Terminated | 28 |